Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Table 1
Baseline characteristics of the study groups are shown in three groups.
Groups
Eyes (n)
Gender (n)
Age (years)
AL (mm)
MD (dB)
Time (days)
Pretreatment IOP (mmHg)
Posttreatment IOP (mmHg)
Antiglaucoma medications (n)
M/F
PXG
50
25/25
75.36 ± 6.75
23.19 ± 0.99
−16.76 ± 9.53
58.70 ± 50.56
30.36 ± 7.82
16.30 ± 2.97
2.78 ± 1.02
POAG
56
22/34
73.66 ± 6.23
23.26 ± 0.88
−14.66 ± 8.98
65.75 ± 49.92
27.43 ± 8.11
16.16 ± 2.37
2.69 ± 1.01
Control
54
20/34
73.70 ± 4.85
23.22 ± 0.89
−1.04 ± 0.41
—
—
15.46 ± 2.52
—
χ2/F
2.030
1.355
0.084
68.338
0.01
0.448
1.702
197.657
0.362
0.261
0.919
＜0.001
0.473
0.062
0.186
＜0.001
PXG: pseudoexfoliative glaucoma; POAG: primary open-angle glaucoma; M: male; F: female; IOP: intraocular pressure; AL: axial length; MD: mean defect; Time: duration between the first diagnosis and study enrolment.
